每周股票复盘：迈得医疗（688310）Q3净利增224%但扣非净利亏损

Core Viewpoint - The recent performance of Maide Medical (688310) shows a decline in stock price and mixed financial results, with a notable increase in net profit but a significant drop in non-recurring net profit [1][3]. Stock Performance - As of October 31, 2025, Maide Medical's stock closed at 19.33 yuan, down 7.51% from the previous week [1]. - The stock reached a peak of 21.44 yuan on October 27 and a low of 18.76 yuan on October 30 [1]. - The company's current market capitalization is 3.213 billion yuan, ranking 69th out of 78 in the automation equipment sector and 4400th out of 5163 in the A-share market [1]. Shareholder Changes - As of September 30, 2025, the number of shareholders increased to 4528, up by 723 or 19.0% from June 30 [2]. - The average number of shares held per shareholder decreased from 43,700 to 36,700 shares, with an average holding value of 736,000 yuan [2]. Financial Performance - For Q3 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31% [3]. - The net profit attributable to shareholders was 8.8367 million yuan, up 15.82% year-on-year [3]. - The non-recurring net profit was -1.2785 million yuan, a significant decline of 526.58% year-on-year [3]. - In Q3 alone, the main revenue was 83.643 million yuan, reflecting a 54.38% year-on-year increase [3]. - The net profit for Q3 was 2.7916 million yuan, a substantial increase of 224.07% year-on-year [3]. - The non-recurring net profit for Q3 was 1.2364 million yuan, up 118.23% year-on-year [3]. - The company's debt ratio stands at 29.86%, with investment income of 167,600 yuan and financial expenses of -523,600 yuan, while the gross profit margin is 40.19% [3]. Company Announcements - On October 27, 2025, Maide Medical's fifth supervisory board meeting approved the Q3 report and the postponement of fundraising projects, confirming that the delay would not harm the company's or shareholders' interests [3]. - The "Annual Production of 35 Sets of Drug-Device Combination Intelligent Equipment Expansion Project" has been postponed to November 2026 due to production layout adjustments and equipment debugging, with a cumulative investment of 37.9365 million yuan, representing 59.08% of the planned investment [3]. Legal Opinions - On October 30, 2025, Maide Medical held its first extraordinary general meeting of 2025, where 13 resolutions, including changes to the supervisory board and amendments to the articles of association, were approved [4]. - The meeting had 18 attendees representing 66.7103% of the voting shares, and the legal opinion confirmed the legality and validity of the meeting procedures and resolutions [4].